Results 261 to 270 of about 175,041 (315)
Some of the next articles are maybe not open access.

Related searches:

Human papillomavirus

Current Opinion in Obstetrics and Gynecology, 1992
In the past year, new data have been published on the molecular biology of human papillomavirus infections and their relationship to cervical neoplasia. As molecular techniques have become more sophisticated and as the molecular knowledge of human papilloma-virus infections has been pursued in greater depth, it is increasingly apparent that this human ...
R M, Richart, T C, Wright
openaire   +2 more sources

Papillomavirus and treatment

Antiviral Research, 2006
Human papillomaviruses (HPVs) are small DNA viruses responsible for a broad range of clinical presentations, characterized histologically by the proliferation of epithelial cells. HPVs are responsible for benign as well as malignant lesions, the most frequent of the latter being cervical carcinoma.
openaire   +2 more sources

Prophylactic papillomavirus vaccines

Clinics in Dermatology, 2014
Human papillomaviruses (HPV) are the causative agents of cervical cancer, the third most common cancer in women. The development of prophylactic HPV vaccines Gardasil® and Cervarix® targeting the major oncogenic HPV types is now the frontline of cervical cancer prevention.
Lis, Ribeiro-Müller, Martin, Müller
openaire   +2 more sources

Human papillomavirus infection

Disease-a-Month, 2016
Human papillomavirus (HPV) is a DNA virus that causes a variety of conditions including common warts, condyloma acuminata (anogenital warts), and multiple malignancies involving the squamous epithelium. HPV is a unique oncogenic infectious agent that causes cervical cancer, the second most common cancer in women worldwide.
Jack N, Hutter, Catherine F, Decker
openaire   +2 more sources

Human Papillomavirus Vaccines

Clinical Obstetrics & Gynecology, 2023
Human papillomavirus (HPV) vaccines are highly effective in preventing the transmission of HPV and thus downstream HPV-related lower genital tract neoplasias. First introduced in 2006, the HPV vaccine has demonstrated clinical efficacy in both men and women.
openaire   +2 more sources

THE MALIGNANT POTENTIAL OF PAPILLOMAVIRUS *

Australasian Journal of Dermatology, 1985
SUMMARYPapillomaviruses are double‐stranded DNA viruses which can be classified into groups, types and subtypes on the basis of DNA cross‐hybridisation and restriction endonuclease patterns. In the majority of cases they produce a benign epithelial proliferation. However, restricted types can be associated with malignant transformation.
D, Dyall-Smith, G, Varigos
openaire   +2 more sources

Human Papillomavirus

2012
Human papillomavirus (HPV) is one of the most prevalent sexually transmitted infections throughout the world. It is esti- mated that “as many as 75% of sexually active men and women will have at least one HPV infection in their lifetime.”1 HPV is a viral sexually transmitted infection (STI) primarily spread through sexual contact.
openaire   +1 more source

Papillomavirus and anal carcinoma

International Journal of Colorectal Disease, 1998
Human papilloma virus (HPV; 16 and 18) is known to play an important etiologic role in cervical dysplasia, but its relationship with anal carcinoma is still unclear. Surgical samples from 80 female patients treated for anal epidermoid carcinoma in the Polyclinic of Surgery in Geneva between 1976 and 1989 were retrospectively studied.
Poletti, Pierre-Alexandre Alois   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy